Quarterly report pursuant to Section 13 or 15(d)

License, Clinical Trial and Sponsored Research Agreements (Details)

v3.10.0.1
License, Clinical Trial and Sponsored Research Agreements (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Research and development - licenses acquired $ 0 $ 1,500 $ 75 $ 2,075
Sponsored Research and Clinical Trial Agreements [Member]        
Research and development - licenses acquired 1,290 2,076 2,680 2,605
Manufacturing [Member]        
Research and development - licenses acquired 0 0 75 0
Manufacturing [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Research and development - licenses acquired 115 0 229 0
IL13Ra2 [Member]        
Research and development - licenses acquired 0 0 0 250
IL13Ra2 [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Research and development - licenses acquired 143 1,001 503 1,010
IV/ICV [Member]        
Research and development - licenses acquired 0 0 0 125
Fred Hutch CD20 [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Research and development - licenses acquired 418 0 684 0
CD123 [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Research and development - licenses acquired 114 575 264 595
City Of Hope [Member] | Sponsored Research and Clinical Trial Agreements [Member]        
Research and development - licenses acquired 500 500 1,000 1,000
PSCA [Member]        
Research and development - licenses acquired 0 300 0 300
HER2 [Member]        
Research and development - licenses acquired 0 600 0 600
CS1 [Member]        
Research and development - licenses acquired 0 600 0 600
UCLA [Member]        
Research and development - licenses acquired $ 0 $ 0 $ 0 $ 200